Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008

Prostate

Volumn 75, Issue 7, 2015, Pages 758-763

  Cook, Michael B ^a   Rosenberg, Philip S ^a   McCarty, Frances A ^b   Wu, Manxia ^c   King, Jessica ^c   Eheman, Christie ^c   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

census division; epidemiology; incidence rate; prostate cancer; regional variation; SEER program

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; UNITED STATES; AFRICAN AMERICAN; AGED; BLOOD; ETHNOLOGY; INCIDENCE; LEAST SQUARE ANALYSIS; MIDDLE AGED; PROSTATIC NEOPLASMS; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; KALLIKREINS; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; PREVALENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84926522848     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22958     Document Type: Article

References (18)

1. Brawley OW, Jani AB, Master V,. Prostate cancer and race. Curr Probl Cancer 2007; 31: 211-225.
2. Hankey BF, Ries LA, Edwards BK,. The surveillance, epidemiology, and end Results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8: 1117-1121.
3. Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M, Lee NC, Hall HI,. Building the infrastructure for nationwide cancer surveillance and control-a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 2003; 14: 175-193.
4. Nathan H, Pawlik TM,. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008; 15: 415-423.
5. Thoburn KK, German RR, Lewis M, Nichols PJ, Ahmed F, Jackson-Thompson J,. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 2007; 109: 1607-1616.
6. Zippin C, Lum D, Hankey BF,. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995; 76: 2343-2350.
7. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006; 15: 547-569.
8. Walters KA, Li Y, Tiwari RC, Zou Z,. A Weighted-Least-Squares Estimation Approach to Comparing Trends in Age-Adjusted Cancer Rates Across Overlapping Regions. J Data Sci 2011; 8: 631-644.
9. Li Y, Tiwari RC,. Comparing trends in cancer rates across overlapping regions. Biometrics 2008; 64: 1280-1286.
10. Li Y, Tiwari RC, Zou Z,. An age-stratified poisson model for comparing trends in cancer rates across overlapping regions. Biom J 2008; 50: 608-619.
11. Tiwari RC, Li Y, Zou Z,. Interval Estimation for Ratios of Correlated Age-Adjusted Rates. J Data Sci 2010; 8: 471-482.
12. Romero FR, Romero AW, Almeida RM, Tambara Filho R,. The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis. Int Braz J Urol 2012; 38: 440-447.
13. Ben-Shlomo Y, Evans S, Patel B, Anson K, Muir G, Persad R, Metcalfe C, Chinegwundoh F,;, PROCESS Study Group,. Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: Lessons learnt from the process study. BJU Int 2009; 103: 723-724.
14. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW,. Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men. N Engl J Med 1996; 335: 304-310.
15. Howrey BT, Kuo YF, Lin YL, Goodwin JS,. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States. J Gerontol A Biol Sci Med Sci 2013; 68: 56-61.
16. Espaldon R, Kirby KA, Fung KZ, Hoffman RM, Powell AA, Freedland SJ, Walter LC,. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold. Urology 2014; 83: 599-605.
17. Leal J, Hamdy F, Wolstenholme J,. Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies. Int J Urol 2014.
18. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W,. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 2010; 183: 1792-1796.